{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:44:50Z","timestamp":1792154690404,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009129","name":"Evidence Synthesis Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jval.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:00:21Z","timestamp":1787065221000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping Treatment Effects on Generic Health-Related Quality-of-Life Scales From Disease-Specific Measures Using Bivariate Meta-Analytic Models and Summary Data"],"prefix":"10.1016","author":[{"given":"Ayman S.","family":"Sadek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky J.","family":"Welton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Bujkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2026.07.008_bib1","series-title":"\u201cNICE DSU Technical Support Document 22 Mapping to Estimate Health State Utilities.\u201d","author":"Wailoo","year":"2023"},{"issue":"1","key":"10.1016\/j.jval.2026.07.008_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jval.2016.11.006","article-title":"Mapping to estimate health-state utility from non\u2013preference-based outcome measures: an ISPOR good practices for outcomes research task force report","volume":"20","author":"Wailoo","year":"2017","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2026.07.008_bib3","first-page":"83","article-title":"Challenges in meta-analyses with observational studies","volume":"23","author":"Metelli","year":"2020","journal-title":"BMJ Ment Health"},{"key":"10.1016\/j.jval.2026.07.008_bib4","series-title":"A Generalised Linear Modelling Framework for Pairwise and Network Meta-analysis of Randomised Controlled Trials","author":"Dias","year":"2016"},{"key":"10.1016\/j.jval.2026.07.008_bib5","series-title":"Multivariate meta-analysis of summary data for combining treatment effects on correlated outcomes and evaluating surrogate endpoints","author":"Bujkiewicz","year":"2019"},{"issue":"4","key":"10.1016\/j.jval.2026.07.008_bib6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/sim.1040","article-title":"Advanced methods in meta-analysis: multivariate approach and meta-regression","volume":"21","author":"Van Houwelingen","year":"2002","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jval.2026.07.008_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/sim.2524","article-title":"An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes","volume":"26","author":"Riley","year":"2007","journal-title":"Stat Med"},{"issue":"22","key":"10.1016\/j.jval.2026.07.008_bib8","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1002\/sim.5831","article-title":"Multivariate meta-analysis of mixed outcomes: a Bayesian approach","volume":"32","author":"Bujkiewicz","year":"2013","journal-title":"Stat Med"},{"issue":"7","key":"10.1016\/j.jval.2026.07.008_bib9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/sim.6776","article-title":"Bayesian meta-analytical methods to incorporate multiple surrogate endpoints in drug development process","volume":"35","author":"Bujkiewicz","year":"2016","journal-title":"Stat Med"},{"issue":"17","key":"10.1016\/j.jval.2026.07.008_bib10","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.0.CO;2-M","article-title":"Meta-analysis for the evaluation of potential surrogate markers","volume":"16","author":"Daniels","year":"1997","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jval.2026.07.008_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/0962280216631361","article-title":"Bayesian bivariate meta-analysis of correlated effects: impact of the prior distributions on the between-study correlation, borrowing of strength, and joint inferences","volume":"27","author":"Burke","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"10.1016\/j.jval.2026.07.008_bib12","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1177\/0962280215597260","article-title":"Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints","volume":"26","author":"Bujkiewicz","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jval.2026.07.008_bib13","series-title":"National Axial Spondyloarthritis Society","year":"2026"},{"issue":"12","key":"10.1016\/j.jval.2026.07.008_bib14","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.jval.2026.07.008_bib15","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jval.2026.07.008_bib16","series-title":"SF-36 Physical and Mental Health Summary Scales: A User\u2019s Manual","author":"Ware","year":"1994"},{"key":"10.1016\/j.jval.2026.07.008_bib17","series-title":"TNF-alpha Inhibitors for Ankylosing Spondylitis and axial Spondyloarthritis Without Radiographic Evidence of Ankylosing Spondylitis (Including a Review of Technology Appraisal 143 And Technology Appraisal 233. York: CRD\/CHE Technology Assessment Group","author":"Corbett","year":"2014"},{"issue":"6","key":"10.1016\/j.jval.2026.07.008_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jval.2026.07.008_bib19","series-title":"Secukinumab for Ankylosing Spondylitis After Inadequate Response to Non-Steroidal Antiinflammatory Drugs or TNF-alpha Inhibitors: a Single Technology Assessment","author":"Wolff","year":"2016"},{"issue":"1","key":"10.1016\/j.jval.2026.07.008_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2288-12-27","volume":"12","author":"Lassere","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"10.1016\/j.jval.2026.07.008_bib22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/sim.8465","article-title":"A Bayesian hierarchical meta-analytic method for modelling surrogate relationships that vary across treatment classes","volume":"39","author":"Papanikos","year":"2020","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jval.2026.07.008_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jval.2013.12.006","article-title":"Simultaneous multioutcome synthesis and mapping of treatment effects to a common scale","volume":"17","author":"Lu","year":"2014","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2026.07.008_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1467-985X.2008.00593.x","article-title":"Multivariate meta-analysis: the effect of ignoring within-study correlation","volume":"172","author":"Riley","year":"2009","journal-title":"J R Stat Soc A"},{"key":"10.1016\/j.jval.2026.07.008_bib25","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3","year":"2022"},{"issue":"1","key":"10.1016\/j.jval.2026.07.008_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jval.2013.11.005","article-title":"Use of Bayesian multivariate meta-analysis to estimate HAQ for mapping onto EQ-5D in rheumatoid arthritis","volume":"17","author":"Bujkiewicz","year":"2014","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2026.07.008_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2288-7-3","article-title":"Bivariate random-effects meta-analysis and the estimation of between-study correlation","volume":"7","author":"Riley","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jval.2026.07.008_bib28","series-title":"NICE health technology evaluations: the manual NICE process and methods reference number: PMG36","year":"2026"},{"key":"10.1016\/j.jval.2026.07.008_bib29","series-title":"\u201cNICE DSU Technical Support Document 11: Alternatives to EQ-5D for Generating Health State Utility Values\u201d","author":"Brazier","year":"2011"},{"key":"10.1016\/j.jval.2026.07.008_bib30","series-title":"Ixekizumab for treating active ankylosing spondylitis and non-radiographic axial spondyloarthritis. Technology appraisal guidance. Reference number: TA718","year":"2021"},{"issue":"1","key":"10.1016\/j.jval.2026.07.008_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001955","article-title":"Measuring quality of life of patients with axial spondyloarthritis for economic evaluation","volume":"8","author":"Hernandez Alava","year":"2022","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.jval.2026.07.008_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1524-4733.2008.00428.x","article-title":"Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available","volume":"12","author":"Ara","year":"2009","journal-title":"Value Health"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526025908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526025908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:48:39Z","timestamp":1792151319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301526025908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"alternative-id":["S1098301526025908"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2026.07.008","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping Treatment Effects on Generic Health-Related Quality-of-Life Scales From Disease-Specific Measures Using Bivariate Meta-Analytic Models and Summary Data","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}